BioAdaptives Inc. Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
BioAdaptives Inc. (BDPT) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of -$197.14 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2025-05-13
- BioAdaptives Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-03-31 was -$197.14K.
- BioAdaptives Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2024-12-31 was -$377.39K.
- BioAdaptives Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2024-09-30 was -$37.65K.
- BioAdaptives Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2024-06-30 was -$183.02K.
- BioAdaptives Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2024 was -$904.76K.
- BioAdaptives Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2023 was -$712.47K.
- BioAdaptives Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2022 was -$895.57K.
- BioAdaptives Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2021 was -$1.05M.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2025-03-31 | -$197.14K 10-Q · filed 2025-05-13 | -$574.52K derived: sum of 2 quarters · filed 2025-05-13 | -$612.17K derived: sum of 3 quarters · filed 2025-05-13 | -$795.19K derived: sum of 4 quarters · filed 2025-05-13 |
| 2024-12-31 | -$377.39K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$415.04K derived: sum of 2 quarters · filed 2025-04-15 | -$598.05K derived: sum of 3 quarters · filed 2025-04-15 | -$904.76K 10-K · filed 2025-04-15 |
| 2024-09-30 | -$37.65K 10-Q · filed 2024-11-19 | -$220.67K derived: sum of 2 quarters · filed 2024-11-19 | -$527.37K 10-Q · filed 2024-11-19 | -$795.67K derived: sum of 4 quarters · filed 2025-05-13 |
| 2024-06-30 | -$183.02K 10-Q · filed 2024-08-19 | -$489.72K 10-Q · filed 2024-08-19 | -$758.02K derived: sum of 3 quarters · filed 2025-05-13 | -$771.09K derived: sum of 4 quarters · filed 2025-05-13 |
| 2024-03-31 | -$306.71K 10-Q · filed 2025-05-13 | -$575.01K derived: sum of 2 quarters · filed 2025-05-13 | -$588.07K derived: sum of 3 quarters · filed 2025-05-13 | -$731.99K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$268.30K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$281.36K derived: sum of 2 quarters · filed 2025-04-15 | -$425.28K derived: sum of 3 quarters · filed 2025-04-15 | -$712.47K 10-K · filed 2025-04-15 |
| 2023-09-30 | -$13.06K 10-Q · filed 2024-11-19 | -$156.98K derived: sum of 2 quarters · filed 2024-11-19 | -$444.17K 10-Q · filed 2024-11-19 | -$472.44K derived: sum of 4 quarters · filed 2024-11-19 |
| 2023-06-30 | -$143.92K 10-Q · filed 2024-08-19 | -$431.10K 10-Q · filed 2024-08-19 | -$459.38K derived: sum of 3 quarters · filed 2024-08-19 | -$735.71K derived: sum of 4 quarters · filed 2024-08-19 |
| 2023-03-31 | -$287.19K 10-Q · filed 2024-05-17 | -$315.46K derived: sum of 2 quarters · filed 2024-05-17 | -$591.79K derived: sum of 3 quarters · filed 2024-05-17 | -$815.63K derived: sum of 4 quarters · filed 2024-05-17 |
| 2022-12-31 | -$28.28K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10 | -$304.60K derived: sum of 2 quarters · filed 2024-04-10 | -$528.44K derived: sum of 3 quarters · filed 2024-04-10 | -$895.57K 10-K · filed 2024-04-10 |
| 2022-09-30 | -$276.32K 10-Q · filed 2023-11-13 | -$500.16K derived: sum of 2 quarters · filed 2023-11-13 | -$867.29K 10-Q · filed 2023-11-13 | -$1.08M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$223.84K 10-Q · filed 2023-08-11 | -$590.97K 10-Q · filed 2023-08-11 | -$805.25K derived: sum of 3 quarters · filed 2023-08-11 | -$839.77K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | -$367.13K 10-Q · filed 2023-05-12 | -$581.41K derived: sum of 2 quarters · filed 2023-05-12 | -$615.93K derived: sum of 3 quarters · filed 2023-05-12 | -$925.18K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | -$214.28K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$248.80K derived: sum of 2 quarters · filed 2023-03-31 | -$558.04K derived: sum of 3 quarters · filed 2023-03-31 | -$1.05M 10-K · filed 2023-03-31 |
| 2021-09-30 | -$34.52K 10-Q · filed 2022-11-14 | -$343.76K derived: sum of 2 quarters · filed 2022-11-14 | -$835.66K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | -$309.25K 10-Q · filed 2022-08-12 | -$801.15K 10-Q · filed 2022-08-12 |